Scleroderma ppt

Scleroderma by aseem

Scleroderma 1. SCLERODERMA (systemic sclerosis) 2. Definition Multisystem collagen vascular disease of unknown etiology characterized by fibrosis of the skin with involvement of the internal organs. 3 Scleroderma 1. SCLERODERMA 2. Systemic sclerosis is a rare, heterogeneous, slow- motion disease, with (allegedly) a small window of opportunity to fundamentally change the course of the disease. 3. derived from greek and means hard skin Affects about 250/million = 7500 Canadians Affects mainly women in the prime of their life women: men ratio 3.

Scleroderma (Systemic Sclerosis) Definition 1. Systemic sclerosis (scleroderma) a multisystem disorder characterized by 1) functional and structural abnormalities of - A free PowerPoint PPT presentation (displayed as a Flash slide show) on PowerShow.com - id: 3ba80b-NmNm • Scleroderma is a heterogeneous condition, and requires a multidisciplinary approach • GI, skin, lung tend to be most commonly and severely affected organs • Delineating between limited and diffuse subsets of scleroderma is important, and made primarily on extent of skin involvement rather than pattern/extent of organ involvemen Scleroderma and Inflammatory Myositis - and Inflammatory Myositis Kathryn Dao, MD Arthritis Center February 16, 2006 Scleroderma Skleros- = hard -derma = skin Incidence 1-2/100,000 in USA Peak | PowerPoint PPT presentation | free to vie A Variety Collagenoses, Diseases Including Scleroderma And Dermatomyositis Can Present With 564728 PPT Presentation Summary : A variety collagenoses, diseases including scleroderma and dermatomyositis can present with very characteristic calcifications within the soft tissues

  1. scleroderma.ppt - Free download as Powerpoint Presentation (.ppt), PDF File (.pdf), Text File (.txt) or view presentation slides online. Scribd is the world's largest social reading and publishing site
  2. D Khanna. Diagnosis and treatment of systemic and localized scleroderma Expert Rev. Dermatol. 6 (3), 287-302 (2011) C Denton. Advances in pathogenesis and treatment of systemic sclerosis . Clinical Medicine 2015 Vol 15, No 6: s58-s63 Dra. De Lira CRAIC Mty 3
  3. scleroderma is someone with a genetic predisposition to injury from some external agent, such as a viral or bacterial infection or a substance in the environment. In localized scleroderma, the resulting damage is confined to the skin. In SSc, the process causes injury to blood vessels, or indirectly perturbs the bloo
  4. Scleroderma is a long-lasting disease that affects your skin, connective tissue, and internal organs. It happens when your immune system causes your body to make too much of the protein collagen.
  5. Scleroderma, also known as systemic sclerosis, is a chronic systemic autoimmune disease characterised by hardening (sclero) of the skin (derma). In the more severe form, it also affects internal organs. Scleroderma signs and symptoms vary, depending on which parts of your body are involved. Hardening and tightening of patches of skin
  6. Scleroderma. Scleroderma is a disease of the connective tissue featuring skin thickening that can involve scarring, blood vessel problems, varying degrees of inflammation, and is associated with an overactive immune system. Scleroderma is a chronic connective tissue disease generally classified as one of the autoimmune rheumatic diseases
  7. scleroderma, mixed connective tissue disease, systemic lupus erythematosus, Sjren syndrome, and dermatomyositis. Approximately 95 percent of those diagnosed with scleroderma have Raynaud phenomenon. WHAT CAUSES RAYNAUD PHENOMENON? Most agree that Raynaud phenomenon is caused by a disruption in the normal regulation and response
Systemic sclerosis

PPT - Scleroderma (Systemic Sclerosis) PowerPoint

PPT - Scleroderma PowerPoint presentation free to view

  1. Scleroderma is an aspect of systemic sclerosis, a systemic connective tissue disease that also involves subcutaneous tissue, muscles, and internal organs. Diagnosis is based on clinical manifestations, but tests and procedures may be used initiallly to exclude alternative diagnoses, and later for assessment of organ involvement and monitoring of disease progression (see Presentation and Workup )
  2. Scleroderma, also known as systemic sclerosis, is an autoimmune connective tissue disorder characterized by multisystem fibrosis and soft tissue calcification. As such, it affects many separate organ systems, which are discussed separately: musculoskeletal manifestations of scleroderma; pulmonary manifestations of scleroderma
  3. scleroderma/قشيعة · ورم حبيبي حلقي (جلدية) · lichen sclerosis et atrophicus · بلى حيوي شحماني اضطرابات منوّع
  4. Figure 4 shows an example of tenosynovitis in a patient with linear scleroderma. Enthesitis was diagnosed at the Achilles tendon, as well as at the hamstring and gluteal insertion. Enthesitis was present in two (67%) of three patients with pansclerotic morphea and one (5%) of 19 patients with linear scleroderma
  5. Pulmonary arterial hypertension (PAH) is a progressive vasculopathy that is advanced by the time symptoms develop. As symptoms are nonspecific and the condition uncommon, continued progression toward end-stage disease occurs for an average of 2 years between symptom onset and diagnosis. There is need for earlier diagnosis and treatment, as most patients are severely symptomatic when diagnosed.
  6. •Scleroderma 95% •Hashimoto's thyroiditis 50% •Idiopathic pulmonary fibrosis 50% •Incidence increases with age, chronic infections, and other chronic conditions
Progresive systemic sclerosis

Ppt Scleroderma Powerpoint Presentations and Slides

Systemic sclerosis is a rare chronic disease of unknown cause characterized by diffuse fibrosis and vascular abnormalities in the skin, joints, and internal organs (especially the esophagus, lower gastrointestinal tract, lungs, heart, and kidneys) There is a lot of interest in a recent NIH-funded study that found that stem cell transplants for people with severe scleroderma could have long-term, beneficial results, says Dr. Varga. In the study, chemotherapy and radiation were used to wipe out the person's immune system, and then the person's own stem cells were used to rebuild a new system The American College of Rheumatology Combined Response Index in diffuse cutaneous systemic sclerosis (ACR CRISS) appears to be a consistent and reliable measure of how these patients feel and function, according to data recently presented by Corbus Pharmaceuticals. Notably, the research suggests that this composite measure, which is frequently used in clinical trials of scleroderma, or. The term scleroderma literally means hard skin. But scleroderma (also known as systemic sclerosis, or SSc) is much more than a skin disorder. While nearly all persons with systemic sclerosis have issues with their skin, particularly excessive scarring, swollen, tight, or hard skin on their fingers, they also have organ system involvement Systemic sclerosis (SSc), Scleroderma, Progressive systemic sclerosis. Excluded diseases The clinical manifestations of the disease are vascular and skin changes. Vascular changes include Raynaud's phenomenon, digital Vlachoyiannopoulos PG. Systemic sclerosis (scleroderma). Orphanet encyclopedia, November 2001

Pulmonary Arterial Hypertension Overview for Scleroderma

Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM. 2007 Aug. 100(8):485-94. . Steen VD, Syzd A, Johnson JP, Greenberg A, Medsger TA Jr. Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol. 2005 Apr. 32(4):649-55. . Steen VD, Medsger TA Jr. Case-control study of corticosteroids and. Proximal scleroderma: symmetrical thickening, tightening and induration of the skin of the fingers and the skin proximal to the metacarpophalangeal or metatarsophalangeal joints. These changes can involve the entire limb, face, neck and trunk. Minor Criteria

scleroderma.ppt Esophagus Anatomy - Scrib

Systemic sclerosis (SSc), also known as scleroderma, is a multi-system, autoimmune disease, characterised by functional and structural abnormalities of small blood vessels, fibrosis of skin and internal organs, and production of auto-antibodies Systemic sclerosis, also called scleroderma, is an immune-mediated rheumatic disease that is characterised by fibrosis of the skin and internal organs and vasculopathy. Although systemic sclerosis is uncommon, it has a high morbidity and mortality. Improved understanding of systemic sclerosis has allowed better management of the disease, including improved classification and more systematic. Scleroderma refers to a range of disorders in which the skin and connective tissues tighten and harden. It is a long-term, progressive disease Scleroderma is a skin disease of the connective tissue featuring thickened skin that can involve scarring, blood vessel problems, varying degrees of inflammation and pain, and is associated with an overactive immune system.; CREST syndrome is a limited form of scleroderma. Patients with scleroderma can have specific antibodies (ANA, anticentromere, or anti-topoisomerase) in their blood that.

The aim was to update the 2009 European League against Rheumatism (EULAR) recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic questions. Update of the previous treatment recommendations was performed according to EULAR standard operating procedures. The task force consisted of 32 SSc clinical experts from Europe and the USA, 2 patients nominated by. Sine scleroderma Atteinte viscérale Limitée Absence d'atteinte viscérale Atteinte cutanée Sans atteinte cutanée > 5 ans Poormoghim H, Lucas M, Fertig N, Medsger TA Jr (2000) Systemic sclerosis sine scleroderma. Demographic, clinical, and serological features and survival in forty-eight patients. Arthritis Rheum 43:444-45 areas of linear scleroderma rarely cause trouble and are treated in the same way as morphea. However, larger areas of linear scleroderma that extend over an arm or leg, and areas of linear scleroderma that cross a joint (e.g. across the elbow, wrist, shoulder, knee, ankle, finger), may cause permanent damage. As the ski Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 43(11),2437-2444 (2000). Gyger G, Baron M. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management Morphea, also known as localized scleroderma, is a disorder characterized by excessive collagen deposition leading to thickening of the dermis, subcutaneous tissues, or both. Morphea is classified into circumscribed, generalized, linear, and pansclerotic subtypes according to the clinical presentation and depth of tissue involvement

Esclerodermia - SlideShar

A non-contagious, chronic, multi-system disease. Initial symptoms are non-specific and include fatigue, vague musculoskeletal complaints, diffuse swelling of hands, and Raynaud's phenomenon. Aetiology and pathogenesis are unknown. Disease course is variable, but the condition rarely subsides spon.. Other scleroderma spectrum diseases are not included in this document. Part A: general approach to SSc management. Figure 1 summarizes a general approach to management of SSc. F ig. 1. Open in new tab Download slide. Overview of management of SSc. The principles of current management of SSc are summarized. Once a confirmed diagnosis is.

Scleroderma is a chronic but rare autoimmune disease in which normal tissue is replaced with thick tissue with extra collagen. Although it most often affects the skin, scleroderma also can affect many other parts of the body As scleroderma is a systemic disorder, it is imperitive that these patients receive interdiscipliary care with consistent communication between healthcare providers. Current literature suggests that specific range of motion activities, resistance exercises, and cardiovascular activities may increase a patient's quality of life and decrease.

Scleroderma: Definition, Types, Symptoms, Causes, and

Scleroderma Japan PDF PPT Case Reports Symptoms

The term scleroderma is derived from the Greek words skleros (hard or indurated) and derma (skin) and it is used to describe a disease characterized by progressive skin hardening and induration. Hippocrates first described this condition as thickened skin Ofev (nintedanib) is a treatment for interstitial lung disease caused by systemic scleroderma or scleroderma that affects internal organs and tissues. Ofev is manufactured by Boehringer Ingelheim and has been approved by the U.S. Food and Drug Administration (FDA) to slow the decline of lung function in patients with interstitial lung disease caused by systemic scleroderma The International Workshop on Scleroderma Research is a 4-day research meeting centered on translational medicine related to systemic sclerosis which is organized and executed by the University of Pittsburgh Division of Rheumatology and Clinical Immunology and the Centre for Rheumatology and Connective Tissue Disorders at University College.

Scleroderma Israel PDF PPT Case Reports Symptoms

disease, scleroderma renal crisis (SRC) and GI involvement. The final set of recommendations, grouped according to organ systems and the future research agenda are summarised in table 1 and box 1, respectively. In addition to the main recommendations, the experts decided to formulate, several comments addressing therapeuti Endothelial cell injury is an early and probably initiating event, but the precise aetiology remains unclear. There are similarities between the vasculopathies of different organs, including pulmonary arterial hypertension, scleroderma renal crisis and digital ulcers, of which ET-1 is believed to be an important mediator Systemic sclerosis (SSc) is an autoimmune inflammatory condition. It results in potentially widespread fibrosis and vascular abnormalities, which can affect the skin, lungs, gastrointestinal tract, heart and kidneys. The skin becomes thickened and hard ( sclerotic ). Systemic sclerosis has been subdivided into two main subtypes, according to. Management of digital ulcers in systemic sclerosis. Abstract: Systemic sclerosis (SSc) is a rare disease characterized by autoimmune pathogenesis, alterations to the vascular system, and fibrosis of the skin and internal organs. Digital ulcers (DUs) are common in SSc patients, and represent a major burden for the patients

Scleroderma - Symptoms and causes - Mayo Clini

PPT - Sjögren’s syndrome (SS) PowerPoint Presentation

Scleroderma Clinical Presentation: History, Physical

Scleroderma affects the connective tissues of the body (tissues that hold together joints, muscles, blood vessels and internal organs). The connective tissues of people with scleroderma have too much of a protein called collagen. Collagen is important to give connective tissue its strength, but excess collagen causes hardening and tightening of. Start studying Rheumatology PPT 3. Learn vocabulary, terms, and more with flashcards, games, and other study tools Systemic scleroderma is an autoimmune disorder that affects the skin and internal organs.It is characterized by the buildup of scar tissue (fibrosis) in the skin and other organs. The fibrosis is caused by the body's production of too much collagen, which normally strengthens and supports connective tissues Rare cases of renal disease flares after vaccination against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) have been reported, including IgA nephropathy, membranous nephropathy, minimal change disease, or pauci-immune vasculitis (1). Here we describe an original case of scleroderma renal crisis (SRC) following mRNA vaccination against SARS-CoV-2

Hallerman-Streiff Syndrome | Syndromes: Rapid Recognition

Systemic sclerosis (scleroderma) has a strong predilection in women, with onset typically between ages 30-50 years. Scleroderma kidney disease occurs in 60%-70% of patients with systemic scleroderma, mostly in those with a diffuse, rather than limited, form of cutaneous scleroderma. Kidney disease is evident by hypertension, proteinuria, and loss of glomerular filtration rate 特发性炎性肌病的诊断和治疗 Diagnosis and Treatment of Idiopathic Inflammatory Myopathies炎性肌病的分类,多发性肌炎(polymyositis, PM) 皮肌炎(dermatomyositis, DM) 成人皮肌炎(adult DM) 青少年皮肌炎(juvenile DM) 无肌病的皮肌炎(amyopathic DM) 10 包涵,冰点文

Amyotrophic Lateral Sclerosis Market Global Research Report Forecast till 2027 - Market Analysis The global amyotrophic lateral sclerosis market is anticipated to touch USD 841.6 million at a healthy 7.89% CAGR during the forecast period (2018 2023). ALS or Amyotrophic Lateral Sclerosis is a neurological ailment which affects the nerve cells in the spinal cord and the brain that controls the. Scleroderma. An Autoimmune Project by: Evan Moore and Courtney Blue Honors Anatomy and Physiology. What is Scleroderma?. It is a build up of collagen that effects blood vessels, muscles, skin, and internal organs. Scleroderma is a disease that also affects connective tissues. Slideshow 2583575..

Scleroderma 1 Scleroderma Edward Dwyer, M.D. Division of Rheumatology Scleroderma Progressive Systemic Sclerosis Systemic Sclerosis Nomenclature Synonyms . Scleroderma 2 Scleroderma Chronic systemic autoimmune disease 22-_Dwyer_Scleroderma.ppt Author: Nitin Created Date View PROGRESSIVE SYSTEMIC SCLEROSIS-11-02-14.ppt from MEDS 301 at Egerton University. PROGRESSIVE SYSTEMIC SCLEROSIS DR AYUNGA PHYSICIAN Scleroderma derived from greek and means hard skin Affect

- Scleroderma renal crisis: ACE inhibitor. Vasculitis • Inflammation & necrosis of blood vessel • Perforation & hemorrhage, thrombosis, ischemia 45. 7/18/2018 Template copyright 2005 www.brainybetty.com 46 Vasculitis. 7/18/2018 Template copyright 2005 www.brainybetty.com 47 Scleroderma is rare, and the signs and symptoms are similar to many other diseases. Doctors who most commonly diagnose scleroderma are dermatologists and rheumatologists. Dermatologists have expertise in diagnosing diseases that affect the skin, and rheumatologists specialize in diseases that affect the joints, muscles, and bones Scleroderma is a connective tissue disease that involves changes to the skin, and can also involve changes to the blood vessels and internal organs. It is a chronic, progressive autoimmune disorder where inflammation and the overproduction of collagen accumulate in the body. There are two main types of Scleroderma- Systemic and Localized Chronic diarrhea is defined as an increase in the frequency (more than 2 bowel movements per day) and fluidity of stools for more than 4 weeks duration. It can be divided as watery, fatty or inflammatory according to the stool characteristics. . Mechanisms of Diarrhea Systemic Lupus Systemic Lupus Erythematosus A multi-system autoimmune disease Etiology unknown Most common in women, young to Most common in women, young to middle-aged Highly variable clinical presentation Highly variable clinical presentation in individual patients Harvard-MIT Division of Health Sciences and Technolog

Systemic Sclerosis (SS) Systemic sclerosis (SS) is an autoimmune disorder. This means it's a condition in which the immune system attacks the body These free Healthcare & Medical PPT presentations are all focused on the content needs of the medical and healthcare industry and focus on medical themes related to diseases, healthy lifestyle, medical procedures, as well as specific medical terms and concepts. We invite you to download the free medical PowerPoint presentationsunder this section بعض الأمراض الروماتيزمية، مثل: الذئبة، وتصلب الجلد (Scleroderma)، والتهاب الأوعية الدموية (Vasculitis). انسداد جزئي أو كامل للشريان الذي يزود الكلى بالدم. عوامل خطر الإصابة بالفشل الكلوي المزم Although thick and indurated skin (scleroderma) is the distinguishing hallmark of SSc, skin changes also occur in localized forms of scleroderma, along with multiple metabolic, inherited and autoimmune disorders (Table 353-2).Patients with SSc can be broadly segregated into two major subsets defined by the pattern of skin involvement, clinical and laboratory features, and natural history.

Morphea, also known as localized scleroderma, is an inflammatory disorder characterized by increased deposition of collagen in the skin and subcutaneous tissues leading to sclerosis. The absence of features such as Raynaud's phenomenon, sclerodactyly, nail bed capillary abnormalities and involvement of the internal organs differentiates localized from systemic scleroderma Scleroderma . Localized Scleroderma . 21 #2 - Is the Disease Rare? • For. Treatments, determined by prevalence of the disease in US, so prevalence must be less than 200K . Sickle cell disease • Exception - For. PowerPoint Presentation: Systemic sclerosis (scleroderma) a multisystem disorder characterized by functional and structural abnormalities of blood vessels fibrosis of the skin and internal organs immune system activation autoimmunity Localized scleroderma morphea, linear scleroderma 476 Learning objectives: • Use the epidemiology and natural history of systemic lupus erythematosus (SLE) to inform diagnostic and therapeutic decisions • Describe and explain the key events in the pathogenesis of SLE and critically analyse th

osis in SSc and associated clinical features; molecular studies exploring potential pathogenic mechanisms; and case reports and case series describing new diagnostic approaches and treatments. Summary Calcinosis cutis is the deposition of insoluble calcium in the skin and subcutaneous tissues. It represents a major clinical problem in patients with SSc affecting at least one quarter of. Edward Roddy DM MRCP(UK), David G.I. Scott MD FRCP, in Rheumatology, 2010. DIABETIC CHEIROARTHROPATHY. Diabetic cheiroarthropathy is characterised by an inability to fully extend the metacarpophalangeal joints and scleroderma-like skin thickening (Crispin & Cocer-Varela 2003).It is seen more frequently in insulin-dependent disease and associates with disease duration and vascular complications. sanofi pasteur 299 - TUBERSOL® Package Insert 1 . AHFS Category: 36:84 . Tuberculin Purified Protein Derivative (Mantoux) TUBERSOL ® Rx only . Diagnostic Antige

Introduction. Progressive systemic sclerosis, or scleroderma, is an uncommon connective tissue disease characterized by autoimmunity, diffuse fibrosis in the skin and internal organs, and a vasculopathy with intimal hyperplasia of muscular and elastic arteries, .Raynaud's phenomenon, an excessive vasospastic reaction to cold or stress, precedes diagnosis of scleroderma by months or years, and. Is Scleroderma the only autoimmune condition to give a positive Anti-scl-70 result? According to my lab results anything >1.0 is positive. Is a positive result just a positive result, or do degrees make a difference. I am trying to get an appointment with a Cleveland Clinic Rheumatologist, but nothing is available for 5 weeks. In the meantime. (scleroderma), and 0% to 8% of mixed connective tissue disease (MCTD). • Chromatin antibody is present in >80% of MCTD cases, 37% to 73% of SLE, 14% of systemic sclerosis, 12% of Sjögren syndrome, and 8% of polymyositis. • Ribonucleoprotein (RNP) antibodies target RNP A and/or RNP 68kD proteins; antibodies to one or bot

Scleroderma Lung-Associated Cough. Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the scleroderma lung study. examined whether cough is related to disease activity and its response to immunosuppressive therapy. Most of the subjects in the study had dry. Scleroderma is an umbrella term for a group of autoimmune conditions which all demonstrate the common clinical finding of sclerotic (thickened) skin. Scleroderma may be localized, involving only the skin, or may be part of a more generalized condition known as systemic sclerosis. Patients with systemic sclerosis exhibit sclerotic changes of the. PVOD is a clinicopathologic syndrome that accounts for a small number of PAH cases and is a known complication of scleroderma. 1,2 It is more common than initially realized and may partly explain the poorer response to vasoactive therapy seen in scleroderma-associated PAH relative to idiopathic PAH. 1,2 The pathologic feature of PVOD is.

Scleroderma (systemic sclerosis) is a rare chronic disorder characterized by diffuse fibrosis of the skin and internal organs. The causes of scleroderma are not known, but autoimmunity, endothelial cell damage, and increased production of extracellular matrix appear to play key pathogenic roles Purpose of review . Scleroderma renal crisis (SRC) is a life-threatening manifestation in systemic sclerosis (SSc) and is usually presented by an acute onset of severe hypertension together with an acute kidney injury. We can conceptualize SRC as a systemic syndrome with features that extend beyond the involvement of the kidney This case exemplifies the severe gastrointestinal manifestations of scleroderma. Esophageal, gastric, small intestinal, and colonic motility disorders were present. The patient was unable to survive on oral feedings or tube feedings. He was clinically resistant to the pharmacologic stimulation of gastrointestinal motility. After considerable discussion, the patient was begun on intravenous.

PPT - Pseudohypertension Osler’s Sign and Aortic ArchPPT - Anesthetic management of maxillofacial surgery

Raynaud's is not exactly a disease, but rather it is a symptom of other conditions that may be more serious. Most commonly, Raynaud's is the first manifestation of systemic scleroderma, a connective tissue disease similar to rheumatism. But Raynaud's can be caused by a wide variety of various conditions and diseases Leigh syndrome can be caused by mutations in any of more than 75 different genes.Most of our genes are made up of DNA in the cell 's nucleus (nuclear DNA).Some of our genes are made up of DNA in other cell structures called mitochondria (mitochondrial DNA, or mtDNA).Most people with Leigh syndrome have a mutation in nuclear DNA, and about 20% have a mutation in mtDNA Interpreting pleural fluid results correctly requires an awareness of the possible aetiologies of a pleural effusion and an understanding of the reliability of the outcome of each investigation. All results must be interpreted within each different clinical. Vulvar lichen sclerosus (VLS) is a chronic inflammatory dermatosis characterized by ivory-white plaques or patches with glistening surface commonly affecting the vulva and anus. Common symptoms are irritation, soreness, dyspareunia, dysuria, and urinary or fecal incontinence. Anogenital lichen. O-Z: pill induced esophagitis radiation esophagitis reflux esophagitis / gastroesophageal reflux disease retention cysts rings sarcoma-general scleroderma (systemic sclerosis) small cell neuroendocrine carcinoma spindle cell (squamous) carcinoma squamous cell carcinoma squamous dysplasia squamous papilloma staging ulcer undifferentiated.